Thomas Steffen
University of Zurich
14 Papers
251 Citations
Thomas Steffen is an academic researcher from University of Zurich. The author has contributed to research in topics: Heroin & Medical prescription. The author has an hindex of 10, co-authored 14 publications.
Chat about Author
Papers
Prescription of narcotics for heroin addicts. Main results of the Swiss national cohort study
Ambros Uchtenhagen,Anja Dobler-Mikola,Thomas Steffen,Felix Gutzwiller,Richard Blättler,Silvia Pfeifer +5 more
- 29 Oct 1999
TL;DR: A review of a programme studying the prescription of narcotics for heroin addicts and issues addressed include toxicology side effects, characteristics of patients, changes in criminal behaviour, and political environment.
119
HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme
TL;DR: The tests conducted showed high prevalence and incidence rates of HIV and hepatitis B/C among patients who had consumed intravenous drugs for years, and descriptive analysis in heroin-assisted treatment showed a reduction in infection risk for viral hepatitis corresponding to the lower risk behaviour of patients.
57
Cost-benefit analysis of heroin maintenance treatment.
Felix Gutzwiller,Thomas Steffen +1 more
- 30 Mar 2000
TL;DR: Introduction: cost analysis on the medical prescription of narcotics definition of the problem, scope of the study, procedure, types of costs, validation of the results results, including project comparisons.
32
Feasibility of the annulus fibrosus repair with in situ gelating hydrogels ─ A biomechanical study
Anne-Gita Scheibler,Tobias Götschi,Tobias Götschi,Jonas Widmer,Jonas Widmer,Claude N. Holenstein,Claude N. Holenstein,Thomas Steffen,Roland S. Camenzind,Jess G. Snedeker,Jess G. Snedeker,Mazda Farshad +11 more
TL;DR: While inclusion of a volumetric collagen scaffold led to repair failure, use of FibGen alone demonstrated clinically relevant promise for prevention of mechanical reherniation, outperforming an FDA approved sealant in this ex vivo test series.
Infectious diseases and public health: risk-taking behavior during participation in the Swiss program for a medical prescription of narcotics (PROVE).
TL;DR: During treatment, a significant reduction in risk-taking behavior was observed in a target population of heroin-dependent persons who failed in previous treatments, and this confirms that a group of drug dependence with severe medical problems was reached in accordance with the admission criteria for the studies.
23